What This Means
This research suggests that insulin resistance — measured using a calculated index called TyG-BMI (which combines triglyceride, glucose, and body mass index values) — is a meaningful predictor of ischemic cardiomyopathy (ICM), a form of heart disease caused by reduced blood flow to the heart muscle. Researchers studied 1,603 patients and used statistical methods to identify 11 independent risk factors for ICM, including TyG-BMI, age, heart pumping function (ejection fraction), cholesterol ratios, sex, individual cholesterol measures, body mass index, hemoglobin levels, diabetes, and hypertension. They then used these factors to build and compare eight different machine learning (AI-based) prediction models.
The XGBoost model outperformed the other seven models and was selected as the best tool for predicting ICM risk. The researchers validated this model using calibration plots (showing its predictions matched real-world outcomes) and decision curve analysis (showing it provides clinically meaningful guidance). To make the model accessible to healthcare providers, they also developed an online calculator and used a technique called SHAP values to visually explain which factors most strongly influenced each prediction.
This research suggests that relatively simple blood tests and measurements — particularly those reflecting insulin resistance and cholesterol metabolism — could be combined into an accessible tool to help identify patients at elevated risk for ischemic cardiomyopathy. If validated in broader populations, such a tool could support earlier intervention and more targeted monitoring for at-risk individuals.